Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° Π½ΠΎΠ²ΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π³Π΅Π½ΠΎΠ΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠ΅ΠΊΠ° ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΈΡ ΡΠΎΠ»ΠΈ Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ ΠΏΡΠΎΡΠΈΠ²ΠΎΡΠΏΠΈΠ·ΠΎΠΎΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
ΠΠΏΡΠΎΠ±Π°ΡΠΈΡ ΡΠ°Π±ΠΎΡΡ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Π΄ΠΎΠ»ΠΎΠΆΠ΅Π½Ρ ΠΈ ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½Ρ Π½Π°: ΠΠ΅ΠΆΠ΄ΡΠ½Π°ΡΠΎΠ΄Π½ΠΎΠΉ Π½Π°ΡΡΠ½ΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅ΡΠ΅Π½ΡΠΈΠΈ ΠΌΠΎΠ»ΠΎΠ΄ΡΡ ΡΡΠ΅Π½ΡΡ «ΠΡΠΎΠ±Π»Π΅ΠΌΡ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³Π° ΠΈ Π³Π΅Π½ΠΎΠ΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΡ Π±ΠΎΠ»Π΅Π·Π½Π΅ΠΉ ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ » (ΠΠ»Π°Π΄ΠΈΠΌΠΈΡ, 2004) — VI Π‘ΠΈΠ±ΠΈΡΡΠΊΠΎΠΉ Π²Π΅ΡΠ΅ΡΠΈΠ½Π°ΡΠ½ΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅ΡΠ΅Π½ΡΠΈΠΈ «ΠΠΊΡΡΠ°Π»ΡΠ½ΡΠ΅ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ Π²Π΅ΡΠ΅ΡΠΈΠ½Π°ΡΠ½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ» (ΠΠΎΠ²ΠΎΡΠΈΠ±ΠΈΡΡΠΊ, 2006) — III Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅ΡΠ΅Π½ΡΠΈΠΈ Ρ ΠΌΠ΅ΠΆΠ΄ΡΠ½Π°ΡΠΎΠ΄Π½ΡΠΌ ΡΡΠ°ΡΡΠΈΠ΅ΠΌ «ΠΡΠΎΠ±Π»Π΅ΠΌΡ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- 1. ΠΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- 1. 1. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠ΅ΠΊΠ°, ΠΎΠ±ΡΠ°Ρ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° Π²ΠΎΠ·Π±ΡΠ΄ΠΈΡΠ΅Π»Ρ
- 1. 2. ΠΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ Π³Π΅Π½ΠΎΠΌΠ° Π²ΠΈΡΡΡΠ° Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠ΅ΠΊΠ°
- 1. 2. 1. UL ΠΎΠ±Π»Π°ΡΡΡ
- 1. 2. 2. US ΠΎΠ±Π»Π°ΡΡΡ
- 1. 2. 3. RL ΠΎΠ±Π»Π°ΡΡΡ
- 1. 2. 4. RS ΠΎΠ±Π»Π°ΡΡΡ
- 1. 3. Π¦ΠΈΠΊΠ» ΡΠ°Π·Π²ΠΈΡΠΈΡ Π²ΠΈΡΡΡΠ°, ΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ
- 1. 3. 1. ΠΠ°ΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ Π² Π΅ΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ ΡΡΠ»ΠΎΠ²ΠΈΡΡ
- 1. 3. 2. Π‘ΡΠ°Π΄ΠΈΡ ΡΠ°Π½Π½Π΅ΠΉ ΡΠΈΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ
- 1. 3. 3. Π‘ΡΠ°Π΄ΠΈΡ Π»Π°ΡΠ΅Π½ΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ
- 1. 3. 4. ΠΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½Π°Ρ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ ΠΏΠ΅ΡΡΠ΅Π²ΡΡ ΡΠΎΠ»Π»ΠΈΠΊΡΠ»ΠΎΠ²
- 1. 4. ΠΠ°ΠΊΡΠΈΠ½Π°ΡΠΈΡ
- 1. 5. ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ°
- 1. 5. 1. ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΠΠ ΠΏΡΡΠ΅ΠΌ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΈΡ Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΠΠ
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠΎΡΠΎΠ²ΠΈΠ½ Π .Π. ΠΠΎΠ»Π΅Π·Π½Ρ ΠΠ°ΡΠ΅ΠΊΠ° — ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° ΠΌΠΈΡΠΎΠ²ΠΎΠ³ΠΎ ΠΏΡΠΈΡΠ΅Π²ΠΎΠ΄ΡΡΠ²Π° / Π . Π. ΠΠΎΡΠΎΠ²ΠΈΠ½, Π. Π. ΠΡΠΈΠ΄ΡΠ±Π°ΠΉΠ»ΠΎ // Π‘ΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ Π±ΠΎΠ»Π΅Π·Π½Π΅ΠΉ ΠΏΡΠΈΡ: ΠΌΠ°Ρ. Π½Π°ΡΡΠ½ΠΎ ΠΏΡΠ°ΠΊΡ. ΠΊΠΎΠ½Ρ. ΠΠΎΠ²ΠΎΡΠΈΠ±ΠΈΡΡΠΊ 2001 Π³.
- ΠΠΎΡΠΎΠ²ΠΈΠ½ Π .Π. ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠ΅ΠΊΠ° ΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ ΠΌΠ΅Ρ Π±ΠΎΡΡΠ±Ρ Ρ Π½Π΅ΠΉ Π² ΠΏΡΠΈΡΠ΅Ρ ΠΎΠ·ΡΠΉΡΡΠ²Π°Ρ ΠΏΡΠΎΠΌΡΡΠ»Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΈΠΏΠ°: ΠΠ²ΡΠΎΡΠ΅Ρ. Π΄ΠΈΡ. Π΄ΠΎΠΊΡ. Π²Π΅Ρ. Π½Π°ΡΠΊ. ΠΠ΅Π½ΠΈΠ½Π³ΡΠ°Π΄, 1989.
- ΠΡΠ»ΡΡΠ±Π΅ΠΊΠΎΠ²Π° Π¨. Π. ΠΠΎΠ»Π΅Π·Π½Ρ ΠΠ°ΡΠ΅ΠΊΠ°: ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ Π΄Π»Ρ Π²Π΅ΡΠ΅ΡΠΈΠ½Π°ΡΠ½ΡΡ Π²ΡΠ°ΡΠ΅ΠΉ / Π¨. Π. ΠΡΠ»ΡΡΠ±Π΅ΠΊΠΎΠ²Π°, Π. Π. ΠΡΡΠ΅Π², Π. Π. ΠΡΡΠ΅Π²Π°, Π. Π. ΠΠ΅Π»ΡΠ½ΠΈΠΊΠΎΠ², Π. Π. ΠΠ΅Π²ΠΈΠ½ΡΠΊΠΈΠΉ, -ΠΠ»Π°Π΄ΠΈΠΌΠΈΡ.: ΠΠ·Π΄-Π²ΠΎ ΠΠΠΠΠΠ, 2001. -40Ρ.
- ΠΡΠΊΠΈΠ½Π° Π.Π. ΠΠ°ΠΊΡΠΈΠ½Π° ΠΏΡΠΎΡΠΈΠ² Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠ΅ΠΊΠ°, ΠΈ ΠΎΡΠ΅Π½ΠΊΠ° Π΅Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠΌΠ΅Π½ΡΠ½ΡΠΌ Π°Π½Π°Π»ΠΈΠ·ΠΎΠΌ: ΠΠ²ΡΠΎΡΠ΅Ρ. Π΄ΠΈΡ. Π΄ΠΎΠΊΡ. Π±ΠΈΠΎΠ». Π½Π°ΡΠΊ. ΠΠΎΡΠΊΠ²Π°, 1992.-51 Ρ.
- ΠΡΠΊΠΈΠ½Π° Π.Π. Π’Π΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΏΡΠ΅Π΄ΠΏΠΎΡΡΠ»ΠΊΠΈ ΠΈΠ·Π³ΠΎΡΠΎΠ²Π»Π΅Π½ΠΈΡ ΠΌΠΎΠ½ΠΎ-, Π±ΠΈ- ΠΈ ΠΏΠΎΠ»ΠΈΠ²Π°Π»Π΅Π½ΡΠ½ΠΎΠΉ Π²Π°ΠΊΡΠΈΠ½Ρ ΠΏΡΠΎΡΠΈΠ² Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠ΅ΠΊΠ°. // Π’Π΅Π·. ΠΠΎΠΊ. ΠΠ°ΡΡΠ½.-ΠΏΡΠΎΠΈΠ·Π². ΠΠΎΠ½Ρ. «100 Π»Π΅Ρ ΠΡΡΡΠΊΠΎΠΉ Π±ΠΈΠΎΡΠ°Π±ΡΠΈΠΊΠ΅ ΠΈ Π°Π³ΡΠΎΠΏΡΠΎΠΌΡΡΠ»Π΅Π½Π½ΠΎΠ΅&trade- Π ΠΎΡΡΠΈΠΈ». ΠΡΡΡΠΊ: 1996, Ρ. 184−189.
- ΠΠΎΠ»Π΅Ρ ΠΈΠ½ Π‘.Π. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π²ΠΈΡΡΡΠ° Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠ΅ΠΊΠ° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ°Π·Π½ΠΎΠΉ ΡΠ΅ΠΏΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ: ΠΠ²ΡΠΎΡΠ΅Ρ. Π΄ΠΈΡ. ΠΊΠ°Π½Π΄. Π±ΠΈΠΎΠ». Π½Π°ΡΠΊ. -ΠΠ»Π°Π΄ΠΈΠΌΠΈΡ, 2002. -26 Ρ.
- ΠΡΠΈΡΠ° ΡΠ΅Π»ΡΡΠΊΠΎΡ ΠΎΠ·ΡΠΉΡΡΠ²Π΅Π½Π½Π°Ρ. ΠΠ΅ΡΠΎΠ΄Ρ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠ΅ΠΊΠ°: ΠΠΠ‘Π’ 25 586–83. — 6Ρ.
- Π‘ΡΡΠΈΠ½ Π.Π. ΠΠΎΠ»Π΅Π·Π½Ρ ΠΠ°ΡΠ΅ΠΊΠ° / Π. Π. Π‘ΡΡΠΈΠ½, Π. Π―. Π‘Π°ΠΌΡΠΉΠ»Π΅Π½ΠΊΠΎ, Π. Π. Π‘ΠΎΠ»ΠΎΠ²ΡΠ΅Π², Π. Π Π€ΠΎΠΌΠΈΠ½Π° // ΠΠΈΡΡΡΠ½ΡΠ΅ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ .- Π: ΠΠΠΠ’ΠΠΠ, -1998.-Π‘. 689−721.
- Π―ΠΊΠΎΠ²Π»Π΅Π²Π° Π.Π., ΠΠ°Π·ΡΡΠ΅Π½ΠΊΠΎ Π. Π. ΠΠΈΠ½ΠΎΠ³ΡΠ°Π΄ΠΎΠ² Π.Π. ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΠ²ΠΎΠΉΡΡΠ² ΡΡΠ°ΠΌΠΌΠ° ΠΠ΅ΠΊΠ°Π²Π° Π²ΠΈΡΡΡΠ° Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠ΅ΠΊΠ° Π² ΠΎΠΏΡΡΠ°Ρ Π½Π° ΡΡΠΏΠ»ΡΡΠ°Ρ / Π. Π. Π―ΠΊΠΎΠ²Π»Π΅Π²Π°, Π. Π. ΠΠ°Π·ΡΡΠ΅Π½ΠΊΠΎ, Π. Π. ΠΠΈΠ½ΠΎΠ³ΡΠ°Π΄ΠΎΠ² // ΠΠΎΠΏΡ. Π²ΠΈΡΡΡ.- 1973.- N5.-Π‘.588.
- Π―ΡΡΠ³ΠΈΠ½Π° Π.Π. ΠΠ½ΡΠΈΠ³Π΅Π½Π½ΡΠ΅ ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π΅Π½Π½ΡΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΡΡΠ°ΠΌΠΌΠΎΠ² Π²ΠΈΡΡΡΠ° Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠ΅ΠΊΠ° ΠΏΡΠΈ ΡΠΎΠ·Π΄Π°Π½ΠΈΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΡ ΠΈ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠ²Π΅Π½Π½ΡΡ Π²Π°ΠΊΡΠΈΠ½: ΠΠ²ΡΠΎΡΠ΅Ρ. Π΄ΠΈΡ. Π΄ΠΎΠΊΡ. Π±ΠΈΠΎΠ». Π½Π°ΡΠΊ. Π©Π΅Π»ΠΊΠΎΠ²ΠΎ, 2005 — 54 Ρ.
- Abujoub A. Development of a sustainable chick cell line infected with Marek’s disease virus / A. Abujoub, P.M. Coussens // Virology. -1995. —Dec.20. -№ 214(2).-P.541−549.
- Afonso C.L. The genome of turkey herpesvirus / C.L. Afonso, E.R. Tulman, Z. Lu, L. Zsak, D.L. Rock, G.F. Kutish // J. Virol. -2001. -Jan-75(2). -P.971−978.
- ΠΠ M.A. Characterization Characterization of an essential HSV-1 protein encoded by the UL25 gene reported to be involved in virus penetration and capsid assembly / M.A. Ali, B. Forghani, E.M. Cantin // Virology. -1996. -Feb.216(1) -P.278−83.
- Anderson A.S. Complete nucleotide sequence of the Marek’s disease virus ICP4 gene / A.S. Anderson, A. Francesconi, R.W. Morgan // Virology. -1992. -Aug. 189(2).-P.657−667.
- Anobile J.M. Nuclear localization and dynamic properties of the Marek’s disease virus oncogene products Meq and Meq/vIL8 / J.M. Anobile, V. Arumugaswami, D. Downs, K. Czymmek, M. Parcells, C.J. Schmidt // J. Virol. -2006. -Feb.80(3). -P.l 160−1166.
- Bacon L.D. Genetic resistance to Marek’s disease / L.D. Bacon, H.D. Hunt, H.H. Cheng // Curr. Top. Microbiol. Immunol. -2001. -№ 255 -P.121−141.
- Baines J.D. The herpes simplex virus 1 UL11 proteins are associated with cytoplasmic and nuclear membranes and with nuclear bodies of infected cells / J.D. Baines, R.J. Jacob, L. Simmerman, B. Roizman // J. Virol. -1995. -№ 69. -P.825−833.
- Baigent S.J. Differential susceptibility to Marek’s disease is associated with differences in number, but not phenotype or location, of pp38+ lymphocytes / S.J. Baigent, L.J. Ross, T.F. Davison // J. Gen. Virol. -1998. -Nov.79(Ptl 1). -P.2795−2802.
- Baigent S. Real-time quantitative PCR for Marek’s disease vaccine virus in feather samples: applications and opportunities / S. Baigent, V. Nair, R. Currie//Dev. Biol. (Basel). -2006a. -№ 126. -P.271−281.
- Baigent S.J. Vaccinal control of Marek’s disease: current challenges, and future strategies to maximize protection / S.J. Baigent, L.P. Smith, V.K. Nair, R.J. Currie // Vet. Immunol. Immunopathol. -2006b. -Jul. 15.112(1−2). -P.78−86.
- Baigent S.J. Correlation of Marek’s disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model / S.J. Baigent, L.P. Smith, R.J. Currie, V.K. Nair // Avian Pathol. -2007. -Dec.36(6). -P.467−74.
- Baines J.D. The UL20 gene of herpes simplex virus 1 encodes a function necessary for viral egress / J.D. Baines, P.L. Ward, G. Campadelli-Fiume, B. Roizman // J. Virol. -1991a. -Dec.65(12) -P.6414−24.
- Baines J.D. The open reading frames UL3, UL4, UL10, and UL16 are dispensable for the replication of herpes simplex virus 1 in cell culture / J.D. Baines, B. Roizman B. // J Virol. -1991b. -Feb.65(2). -P.938−944.
- Baines J.D. The UL10 gene of herpes simplex virus 1 encodes a novel glycoprotein, gM, which is present in the virion and in the plasma membrane of infected cells / J.D. Baines, B. Roizman // J. Virol. -1993a. -Mar.67(3). -P.1441−1452.
- Baines J.D. The UL11 gene of herpes simplex virus 1 encodes a function that facilitates nucleocapsid envelopment and egress from cells / J.D. Baines JD, B. Roizman // J. Virol. -1993b. -№ 66: 5 168−5 174
- Bagust Π’. ΠΠ°ΡΠΈΠ½Π³ΠΎΡΡΠ°Ρ Π΅ΠΈΡ / Π’. Bagust, J. Guy // ΠΠΎΠ»Π΅Π·Π½ΠΈ Π΄ΠΎΠΌΠ°ΡΠ½Π΅ΠΉ ΠΈ ΡΠ΅Π»ΡΡΠΊΠΎΡ ΠΎΠ·ΡΠΉΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΏΡΠΈΡΡ ΠΏΠΎΠ΄ ΡΠ΅Π΄. Π. Π£. ΠΡΠ»Π½Π΅ΠΊΠ° (ΠΈ Π΄Ρ.). —Π.: ΠΠΊΠ²Π°ΡΠΈΡΠΌ, 2003.-Π‘. 608−620.
- Barrow A.D. Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek’s disease virus / A.D. Barrow, S.C. Burgess, S.J. Baigent, K. Howes, V.K. Nair // J. Gen. Virol. -2003. -Oct.84(PtlO). -P.2635−2645.
- Bell S. Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1 / S. Bell, M. Cranage, L. Borysiewicz, T. Minson // J. Virol. -1990. -May.64(5). -P.2181−2186.
- Blaho J.A. An amino acid sequence shared by the herpes simplex virus 1 a regulatory proteins 0, 4, 22 and 27 predicts the nucleotidylylation of the
- UL21, UL31, UL47 and UL49 gene products / J.A. Blaho, C. Mitchell, B. Roiz-man // J. Biol. Chem. -1994. -№ 269.-P. 17 401−17 410.
- Bradley G. Loss of Marek’s disease virus tumorigenicity is associated with truncation of RNAs transcribed with BamHI-H / G. Bradley, G. Lancz, A. Tanaka, M. Nonoyama // J. Virol. -1989. -0ct.63(10). -4129−4135.
- Bublot M. Vaccination against Marek’s disease / M. Bublot, J. Sharma // Marek’s Disease — An Evolving Problem by F. Davisom and T. Vengupal Elsevier. 2004.
- Bulow V.V. Differentiation between strains of Marek’s disease virus and turkey herpesvirus by immunofluorescence assays / V.V. Bulow, P.M. Biggs // Avian Pathol. -1975 -№ 4(2) -P.133−146.
- Buscaglia C. Effect of immunocompetence on the establishment and maintenance of latency with Marek’s disease herpesvirus / C. Buscaglia, B.W. Calnek, K.A. Schat // J. Gen. Virol. -1988a. -May.69(Pt5). -P.1067−1077.
- Buscaglia C. Maintenance of Marek’s disease herpesvirus latency in vitro by a factor found in conditioned medium / C. Buscaglia, B.W. Calnek // J. Gen. Virol. -1988b. -Nov.69(Ptl 1). -P.2809−2818.
- Buscaglia C. Effect of reticuloendotheliosis virus and infectious bursal disease virus on Marek’s disease herpesvirus latency / C. Buscaglia, B.W. Calnek, K.A. Schat // Avian Pathol. -1989. -Apr. 18(2). -P.265−281.
- Calder J.M. Herpes simplex virus helicase-primase: the UL8 protein is not required for DNA-dependent ATPase and DNA helicase activities / J.M. Calder, N.D. Stow//Nucleic. Acids Res. -1990. -№ 18. -P.3573−3578.
- Calnek B.W. Marek’s disease a model for herpesvirus oncology / B.W. Calnek // Crit. Rev. Microbiol. -1986. -№ 12(4) -P.293−320.
- Calnek B.W. Pathogenesis of Marek’s disease virus infection / B.W. Calnek // Curr. Top. Microbiol. Immunol. -2001. -№ 255. -P.25−55.
- Calnec B.W. ΠΠΎΠ»Π΅Π·Π½Ρ ΠΠ°ΡΠ΅ΠΊΠ° / B.W. Calnek, R.L. Witter // ΠΠΎΠ»Π΅Π·Π½ΠΈ Π΄ΠΎΠΌΠ°ΡΠ½Π΅ΠΉ ΠΈ ΡΠ΅Π»ΡΡΠΊΠΎΡ ΠΎΠ·ΡΠΉΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΏΡΠΈΡΡ ΠΏΠΎΠ΄ ΡΠ΅Π΄. Π. Π£. ΠΡΠ»Π½Π΅ΠΊΠ° (ΠΈ Π΄Ρ.). —Π.: ΠΠΊΠ²Π°ΡΠΈΡΠΌ, 2003. Π‘. 426−429.
- Cantello J.L. Marek’s disease virus latency-associated transcripts belong to a family of spliced RNAs that are antisense to the ICP4 homolog gene / J.L. Cantello, M.S. Parcells, A.S. Anderson, R.W. Morgan // J. Virol. -1997. -Feb.71(2). -P. 1353−61.
- Carrozza J.H. Role of desquamated epithelial cells in transmission of Marek’s disease / J.H. Carrozza, T.N. Fredrickson, R.P. Prince, R.E. Luginbuhl // Avian Dis. -1973. -Oct.-Dec.l7(4). -P.767−81.
- Chang K.S. Diversity (polymorphism) of the meq gene in the attenuated Marek’s disease virus (MDV) serotype 1 and MDV-transformed cell lines / K.S. Chang, K. Ohashi, M. Onuma // J. Vet. Med. Sci. -2002. -Dec.64(12). -P.1097−1101.
- Chen X. Multiple bidirectional initiations and terminations of transcription in the Marek’s disease virus long repeat regions / X.B. Chen, L.F. Velicer //J. Virol. -1991. -May. 65(5) -P.2445−2451.
- Cho K.O. Sequential skin lesions in chickens experimentally infected with Marek’s disease virus / K.O. Cho, M. Mubarak, T. Kimura, K. Ochiai, C. Ita-kura // Avian. Pathol. -1996. -Jun.25(2). -P.325−343.
- Churchill A.E. Agent of Marek’s disease in tissue culture / A.E. Churchill, P.M. Biggs //Nature. -1967. -M.29. -№ 215(5100). -P.528−530.
- Churchill A.E. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek’s disease (strain HPRS-16) on passage in cell culture / A.E. Churchill, R.C. Chubb, W. Baxendale // J. Gen. Virol. -1969. -Jun.4(4). -P.557−564.
- Cohen G.H. Type-Common Cp-I Antigen Of Herpes Simplex Virus Is Associated With A 59 000-Molecular-Weight Envelope Glycoprotein / G.H. Cohen, M. Katze, C. Hydrean-Stern, R.J. Eisenberg // J. Virol. -1978. -Jul.27(l) -P. 172−81.
- Coyne S.R. Comparative analysis of the Schleicher and Schuell Iso-Code Stix DNA isolation device and the Qiagen QIAamp DNA Mini Kit / S.R. Coyne, P.D. Craw, D.A. Norwood, M.P. Ulrich // J. Clin. Microbiol. -2004. -0ct.42(10). -P.4859−4862.
- Cui Z.Z. Structural analysis and transcriptional mapping of the Marek’s disease virus gene encoding pp38, an antigen associated with transformed cells / Z.Z. Cui, L.F. Lee, J.L. Liu, H.J. Kung // J Virol. 1991 Dec-65(12):6509−15.
- Cui X. Marek’s disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency / X. Cui, L.F. Lee, W.M. Reed, H.J. Kung, S.M. Reddy // J. Virol. -2004. -May.78(9). -P.4753−4760.
- Davidson I. The feather tips of commercial chickens are a favorable source of DNA for the amplification of Marek’s disease virus and avian leukosis virus, subgroup J /1. Davidson, R. Borenshtain // Avian. Pathol. -2002. -Jun.31(3). -P.237−40.
- Dijkstra J.M. Identification and characterization of pseudorabies virus glycoprotein gM as a nonessential virion component / J.M. Dijkstra, N. Visser, T.C. Mettenleiter, B.G. Klupp // J. Virol. -1996. -Aug.70(8). -P.5684−568.
- Dijkstra J.M. Identification and transcriptional analysis of pseudorabies virus UL6 to UL12 genes / J.M. Dijkstra, W. Fuchs, T.C. Mettenleiter, B.G. Klupp // Arch. Virol. -1997. -№ 142(1). -P.17−35.
- Ding J. Marek’s disease virus unique genes pp38 and pp24 are essential for transactivating the bi-directional promoters for the 1.8 kb mRNA transcripts / J. Ding, Z. Cui, L.F. Lee // Virus Genes. -2007. -Dec.35(3). -P.643−650.
- Ellis M.N. Serological responses to Mycoplasma synoviae in chickens infected with virulent or avirulent strains of Marek’s disease virus / M.N. Ellis, C.S. Eidson, J. Brown, O.J. Fletcher, S.H. Kleven // Poult Sci. -1981 -№ 6. -P.1344−1347.
- Emara M.G. Genetic variation in susceptibility to Marek’s disease in a commercial broiler population / M.G. Emara, M.A. Abdellatif, D.L. Pollock, M. Sadjadi, S.S. Cloud, C.R. Pope, J.K. Rosenberger, H. Kim // Avian Dis. -2001. -№ 45(2) -400−409.
- Endoh D. Detection of transcripts of Marek’s disease virus serotype 1 iCP4 homologue (MDV1 ICP4) by in situ hybridization / D. Endoh, Y. ΠΠΎΠΏ, M. Hayashi, T. Morimura, K.O. Cho, T. Iwasaki, F. Sato // J. Vet. Med. Sci. -1996. -0ct.58(10). -P.969−975.
- Frame M.C. Identification Of The Herpes Simplex Virus Protein Kinase As The Product Of Viral Gene Us3 / M.C. Frame, F.C. Purves, D.J. Mcgeoch, H.S. Marsden, D.P. Leader // J. Gen. Virol. -1987. -Oct.68(PtlO). -P.2699−2704.
- Friedman H.M. Glycoprotein Π‘ of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells / H.M. Friedman, G.H. Cohen, R.J. Eisenberg, C.A. Seidel, D.B. Cines // Nature. -1984. -Jun.14−20.309(5969). -P633−635.
- Fukuchi K. The structure of Marek’s disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA / K. Fukuchi, A. Tanaka, L.W. Schierman, R.L. Witter, M. Nonoyama // Proc. Natl. Acad. Sci. USA. -1985. -Feb.82(3).-P.751−754.
- Fuller A.O. Anti-Glycoprotein D Antibodies That Permit Adsorption But Block Infection By Herpes Simplex Virus 1 Prevent Virion-Cell Fusion At The Cell Surface / A.O. Fuller, P.G. Spear // Proc. Natl. Acad. Sci. USA. -1987. -Aug.84(15) -P.5454−5458.
- Geerligs H.J. Determination of optimal conditions for thawing and diluting cell-bound CVI 988 Marek’s disease vaccine and stability of the diluted vaccine / H.J. Geerligs, A. Hoogendam // Avian. Dis. -2007. -Dec.51(4) -P.969−973.
- Gimeno I.M. Future strategies for controlling Marek’s disease / I.M. Gimeno // Marek’s Disease An Evolving Problem by F. Davisom and T. Vengu-pal — Elsevier. 2004.
- Gimeno I.M. Novel criteria for the diagnosis of Marek’s disease virus-induced lymphomas / I.M. Gimeno, R.L. Witter, A.M. Fadly, R.F. Silva // Avian Pathol. -2005. -Aug.34(4). -P.332−340.
- Gimeno I.M. Load of challenge Marek’s disease virus DNA in blood as a criterion for early diagnosis of Marek’s disease tumors / I.M. Gimeno, A.L. Cortes, R.F. Silva//Avian Dis. -2008. -Jun.52(2). -P.203−208.
- Haider S.A. Use of feathers in a gel precipitation test for Marek’s disease / S.A. Haider, R.F. Lapen, S.G. Kenzy // Poult. Sci. -1970. -Nov.49(6). -P. 1654−7.
- Henning L. Rapid DNA extraction for molecular epidemiological studies of malaria / L. Henning, I. Felger, H.P. Beck // Acta. Trop. -1999. -Mar. 15.72(2)-P. 149−55.
- Higgins J.A. Rapid extraction of DNA From Escherichia coli and Cryptosporidium parvum for use in PCR / J.A. Higgins, M.C. Jenkins, D.R. Shel-ton, R. Fayer, J.S. Karns // Appl. Environ. Microbiol. -2001. -Nov.67(ll). -P.5321−5324.
- Hong Y. Identification of an immediate-early gene in the Marek’s disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide / Y. Hong, P.M. Coussens // J. Virol. -1994. -Jun.68(6). -P.3593−3603.
- Hughes A.L. Phylogeny and recombination history of gallid herpesvirus 2 (Marek's disease virus) genomes / A.L. Hughes, P. Rivailler // Virus. Res. -2007 -Dec. 130(1−2) -P.28−33.
- Ikuta K. Monoclonal antibodies reactive with the surface and secreted glycoproteins of Marek’s disease virus and herpesvirus of turkeys / K. Ikuta, S. Ueda, S. Kato, K. Hirai // J. Gen. Virol. -1983. -Dec.64(Ptl2). -P.2597−610.
- Imai K. Characterization of very virulent Marek’s disease viruses isolated in Japan / K. Imai, N. Yuasa, H. Iwakiri, K. Nakamura, H. Hihara, T. Ishita, A. Inamoto, I. Okamoto, K. Ohta, M. Maeda // Avian. Pathol. -1992 -№ 21(1) -P.l 19−26.
- Isfort R.J. Synthesis, processing, and secretion of the Marek’s disease herpesvirus A antigen glycoprotein / R.J. Isfort, R.A. Stringer, H.J. Kung, L.F. Velicer // J. Virol. -1986. -№ 57 -P.464−474.
- Islam A. Quantitative profiling of the shedding rate of the three Marek’s disease virus (MDV) serotypes reveals that challenge with virulent MDV markedly increases shedding of vaccinal viruses / // J. Gen. Virol. -200)7b. — Aug.88(Pt8). -P.2121−2128. /
- Walkden-Brown, P.J. Groves, G.J. Underwood // Avian Pathol. -20 081 -Jun.37(3).1. P.225−235. /f
- Izumiya Y. Identification and transcriptional analysis of the homoinononcogenic Marek’s disease virus serotype 2 / Y. Izumiya, H.K. Jang, H. Ka-shiwase, J.S. Cai, Y. Nishimura, Y. Tsushima, K. Kato, T. Miyazawa, C. Kai, T.
- Mikami // J Gen Virol. -1998. -Aug-79(Pt 8). -P.1997−200l/t
- Izumiya Y. A complete genomic DNA sequence of Marek’s disease virus type 2, strain HPRS24 / Y. Izumiya, H.K. Jang, M. Ono, T. Mikami // Curr. Top. Microbiol. Immunol. -2001 -№ 255 -P.191−221.
- Jacobson J.G. A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture / J.G. Jacobson, S.L. Martin, D.M. Coen // J Virol. 1989 Apr-63(4): 1839−43.
- Jarosinski K.W. Marek’s disease virus: lytic replication, oncogenesis and control / K.W. Jarosinski, B.K. Tischer, S. Trapp, N. Osterrieder // Expert. Rev. Vaccines. -2006 -Dec.5(6) -P.761−772.
- Jarosinski K.W. Horizontal transmission of Marek’s disease virus requires US2, the UL13 protein kinase, and gC / K.W. Jarosinski, N.G. Margulis, J.P. Kamil, S.J. Spatz, V.K. Nair, N. Osterrieder N. // J. Virol. -2007. -Oct.81(19). -P.10 575−10 587.
- Johnson D.C. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gl / D.C. Johnson, M.C. Frame, M.W. Ligas, A.M. Cross, N.D. Stow // J. Virol. -1988. -Apr.62(4) -P. 134 754.
- Jons A. Glycoproteins M and N of pseudorabies virus form a disulflde-linked complex / A. Jons, J.M. Dijkstra, T.C. Mettenleiter // J. Virol. -1998. -Jan.72(l). -P.550−557.
- Kaltenboeck B. Advances in real-time PCR: application to clinical laboratory diagnostics / B. Kaltenboeck, C. Wang // Adv. Clin. Chem. -2005. № 40. -P.219−59.
- Kato S. Marek’s disease vims and herpesvirus of turkeys: antigenic aspects / S. Kato, K. Ikuta, K. Hirai // Prog. Clin. Biol. Res. -1983. -№ 132. -P.71−80.
- Kaul L. Immunopathology of Marek’s disease in quails: presence of anti-nuclear antibody and immune complex / L. Kaul, H.K. Pradhan // Vet. Immunol. Im-munopathol. -1991. -Mar.28(l). -P.89−96.
- Kingham B.F. The genome of herpesvirus of turkeys: comparative analysis with Marek’s disease viruses / B.F. Kingham, V. Zelnik, J. ΠΠΎΡΠ°ΡΠ΅ΠΊ, V. Ma-jerciak, E. Ney, C.J. Schmidt // J Gen Virol. -2001. -May.82(Pt 5) -P.l 123−35.
- Kuhnlein U. Relationship between Marek’s disease and the time course of viral genome proliferation in feather tips / U. Kuhnlein, J.L. Spencer, M. Chan, D. Praslickova, K. Linher, A. Kulenlcamp, G. Ansah // Avian Dis. -2006. -Jun.50(2). -P.173−178.
- Kut E. Assembly of Marek’s disease virus (MDV) capsids using recombinant baculoviruses expressing MDV capsid proteins / E. Kut, D. Rasschaert // J. Gen. Virol. -2004. -Apr.85(Pt 4) -P.769−74.
- Liu J.L. Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serumindependent growth, and inhibition of apoptosis / J.L. Liu, Y. Ye, L.F. Lee, H.J. Kung // J. Virol. -1998. -Jan.72(l) -P.388−95.
- Liu J.L. Functional interactions between herpesvirus oncoprotein MEQ and cell cycle regulator CDK2 / J.L. Liu, Y. Ye, Z. Qian, Y. Qian, D.J. Templeton, L.F. Lee, H.J. Kung // J. Virol. -1999a. -May.73(5). -P.4208−4219.
- Liu J.L. MEQ and V-IL8: cellular genes in disguise? / J.L. Liu, S.F. Lin, L. Xia, P. Brunovskis, D. Li, I. Davidson, L.F. Lee, H.J. Kung // Acta. Virol. -1999b. -Apr-Jun.43(2−3). -P.94−101.
- Lombard M. A brief history of vaccines and vaccination. / M. Lombard, P.P. Pastoret, A.M. Moulin // Rev. Sci. Tech. -2007. -Apr.26(l) -P.29−48.
- MacLean C.A. Gene UL11 of herpes simplex virus type 1 encodes a virion protein which is myristylated / C.A. MacLean, B. Clark, D.J. McGeoch // J. Gen. Virol. -1989. -Dec.70(Ptl2)-P.3147−57.
- MacLean C.A. The myristylated virion proteins of herpes simplex virus type 1: investigation of their role in the virus life cycle / C.A. MacLean, A. Do-lan, F.E. Jamieson, D.J. McGeoch // J. Gen. Virol. -1992. -Mar.73(Pt3) -P.539−547.
- Majerciak V. Increased virulence of Marek’s disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells / V. Majerciak, A. Valkova, D. Szabova, H. Geerligs, V. Zelnik // Acta. Virol. -2001. -Apr.45(2). -P.101−108.
- Makimura K. Mapping of Marek’s disease virus genome: identification of junction sequences between unique and inverted repeat regions / K. Makimura, F.Y. Peng, M. Tsuji, S. Hasegawa, Y. Kawai, M. Nonoyama, A. Tanaka // Virus Genes. 1994 Jan-8(l):15−24.
- Maotani K. Amplification of a tandem direct repeat within inverted repeats of Marek’s disease virus DNA during serial in vitro passage / K. Maotani, A. Kanamori, K. Ikuta, S. Ueda, S. Kato, K. Hirai // J. Virol. -1986. -May.58(2) -P.657−660.
- McGeoch D.J. The genomes of the human herpesviruses: contents, relationships, and evolution / McGeoch D.J. // Annu. Rev. Microbiol. -1989 -№ 43 — P.235−65.
- McKimm-Breschkin J.L. Isolation of very virulent Marek’s disease viruses from vaccinated chickens in Australia / McKimm-Breschkin JL, Faragher JT, Withell J, Forsyth WM. // Austio Vet J. -1990. -Jun-67(6) -P.205−209.
- Milne R.S. Human cytomegalovirus glycoprotein H/glycoprotein L complex modulates fusion-from-without / R.S. Milne, D.A. Paterson, J.C. Booth // J. Gen. Virol. -1998. -Apr.79(Pt4) -P.855−65.
- Mohammadi A. Antibody response of chickens to serotype 1, 2, or 3 Marek’s disease vaccines based on ELISA with infected cells as antigen / A. Mohammadi, J.L. Spencer, M. Chan, M. Ansari Lari // Avian Dis. -2007. -Dec.51(4). -P.982−985.
- Morgan R.W. Marek’s disease virus latency / R.W. Morgan, Q. Xie, J.L. Cantello, A.M. Miles, E.L. Bernberg, J. Kent, A. Anderson // Curr. Top. Microbiol. Immunol. -2001.255. -P.223−43.
- Morimura T. Apoptosis and CD8-down-regulation in the thymus of chickens infected with Marek’s disease virus / T. Morimura, K. Ohashi, Y. ΠΠΎΠΏ, M. Hattori, C. Sugimoto, M. Onuma // Arch. Virol. -1996. -№ 141(11) -P.2243−2249.
- Morrow C. Marek’s disease: a worldwide problem / C. Morrow and F. Fehler // Marek’s Disease An Evolving Problem by F. Davisom and T. Vengupal/ -Elsevier. 2004.
- Murata S. Development of a nested polymerase chain reaction method to detect oncogenic Marek’s disease virus from feather tips / S. Murata, K.S. Chang, S.I. Lee, S. Konnai, M. Onuma, K. Ohashi // J. Vet. Diagn. Invest. -2007. -Sep. 19(5).-P.471−478.
- Nair V. Successful control of Marek’s disease by vaccination / Nair V. // Dev. Biol. (Basel). -2004.119. -P. 147−54.
- Nazerian K. Electron Microscopy of a Herpes Virus Associated with the Agent of Marek’s Disease in Cell Culture / K. Nazerian, B.R. Burmester // Cancer Res. -1968. -Dec.28(12). -P.2454−2462.
- Nazerian K. Attenuation of Marek’s disease virus and study of its properties in two different cell cultures / K. Nazerian // J. Natl. Cancer. Inst. -1970. -Jun.44(6). -P. 1257−1267.
- Niikura M. MDV glycoprotein D is expressed in the feather follicle epithelium of infected chickens / M. Niikura, R.L. Witter, H.K. Jang, M. Ono, T. Mikami, R.F. Silva// Acta. Virol. -1999. -Apr.-Jun.43(2−3). -P. 159−63.
- Ono. M. Detection of Marek’s disease virus serotype 1 (MDV1) glycoprotein D in MDV1- infected chick embryo fibroblasts / M. Ono, H.K. Jang, K.
- Maeda, Y. Kawaguchi, Y. Tohya, M. Niikura, T. Mikami // J. Vet. Med. Sci. -1996. -Aug.58(8) -P.777−780.
- Onuma M. Relation between common antigen and membrane antigens associated with Marek’s disease herpesvirus and turkey herpesvirus infections / M. Onuma, T. Mikami, T.T. Hayashi // Arch. Virol. -1976 -№ 50(4) -P.305−309.
- Osterrieder N. Sequence and initial characterization of the UL10 (glycoprotein M) and UL11 homologous genes of serotype 1 Marek’s Disease / Osterrieder N. // Arch. Virol. -1999. -№ 144(9). -P. 1853−63.
- Osterrieder N. Marek’s disease virus: from miasma to model / N. Osterrieder, J.P. Kamil, D. Schumacher, B.K. Tischer, S. Trapp // Nat. Rev. Microbiol. -2006. -Apr.4(4). -P.283−94.
- Parcells M.S. Retention Of Oncogenicity By A Marek’s Disease Virus Mutant Lacking Six Unique Short Region Genes /M.S. Parcells, A.S. Anderson, T.W. Morgan // J. Virol. -1995 -Dec.69(12). -P.7888−98.
- Parcells M.S. Marek’s disease virus reactivation from latency: changes in gene expression at the origin of replication /M.S. Parcells, V. Arumugaswami, J.T. Prigge, K. Pandya, R.L. Dienglewicz // Poult. Sci. -2003. -Jun.82(6). -P.893−898.
- Peng F. Isolation and characterization of cDNAs from BamHI-H gene family RNAs associated with the tumorigenicity of Marek’s disease virus / F.
- Peng, G. Bradley, A. Tanaka, G. Lancz, M. Nonoyama // J. Virol. -1992. -Dec.66(12). -P.7389−96.
- Pereira L. Function of glycoprotein Π homologues of the family Herpesviridae / L. Pereira // Infect Agents Dis. -1994. -Feb.3(l) -P.9−28.
- Powell P.C. Isolation of very vimlent pathotypes of Marek’s disease virus from vaccinated chickens in Europe / P.C. Powell, F. Lombardini // Vet. Rec. -1986 -Jun.21-l 18(25) -P.688−691.
- Pradhan H.K. Immune complex-mediated glomerulopathy in Marek’s disease / H.K. Pradhan. G.C. Mohanty, W.Y. Lee, L. Kaul, J.M. Kataria // Vet. Immunol. Immunopathol. -1988. -Sep. 19(2). -P.l65−171.
- Qian Z.P. Transactivation activity of Meq, a Marek’s disease herpes-vims bZIP protein persistently expressed in latently infected transformed T cells / Z. Qian, P. Brunovskis, F. Rauscher, L. Lee, H.J. Kung // J Virol. 1995 Jul-69(7):4037−44.
- Rauh I. Pseudorabies vims glycoproteins gll and gp50 are essential for vims penetration /1. Rauh, T.C. Mettenleiter // J. Virol. -1991. -0ct.65(10) -P.5348−56.
- Ren D. Identification and characterization of Marek’s disease vims genes homologous to ICP27 and glycoprotein Π of herpes simplex virus-1 / D. Ren, L.F. Lee, P.M. Coussens // Virology. -1994. -0ct.204(l) -P.242−50.
- Ririe K.M. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction / K.M. Ririe, R.P. Rasmussen, C.T. Wittwer //Anal. Biochem. -1997. -Febl 5.245(2). -P. 154−60.
- Roizman B. The Family Herpesviridae: A Brief Introduction / B. Roizman, P.E. Pellett // Fields Virology. 2001. Lippincott Williams & Wilkins Desktop Division.
- Roop C. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H / C. Roop, L. Hutchinson, D.C. Johnson // J. Virol. -1993. -Apr.67(4). -P.2285−97.
- Ross L. J. Nucleotide sequence and characterization of the Marek’s disease virus homologue of glycoprotein Π of herpes simplex virus / L.J. Ross, M. Sanderson, S.D. Scott, M.M. Binns, T. Doel, B. Milne // J. Gen. Virol. -1989. -№ 70 -P. 1789−1804.
- Ross L.J. Properties and evolutionary relationships of the Marek’s disease virus homologues of protein kinase, glycoprotein D and glycoprotein I of herpes simplex virus / L.J. Ross, M.M. Binns // J. Gen. Virol. -1991. -Apr.72(Pt4). -P.939−947.
- Ross N. Alterations in DNA sequence and RNA transcription of the BamHI-H fragment accompany attenuation of oncogenic Marek’s disease herpesvirus / N. Ross, M.M. Binns, M. Sanderson, K.A. Schat // Virus Genes. -1993. -Feb.7(l). -P. 33−51.
- Rozen S. Primer3 on the WWW for general users and for biologist programmers / S. Rozen, H. Skaletsky // Methods Mol. Biol. -2000. -№ 132. -P.365−386.
- Schat Π.A. Immune responses to Marek’s disease virus infection / K.A. Schat, C.J. Markowski-Grimsrud // Curr. Top. Microbiol. Immunol. -2001- -V.255.-P. 91−120.
- Schat K.A. Understanding Marek’s Disease Immunity: A Continuing Challenge / K.A. Schat // Int. J. Poul. Scien. -2004. -№ 3(l).-P.89−95.
- Schumacher D. Glycoproteins E and I of Marek’s disease virus serotype 1 are essential for virus growth in cultured cells / D. Schumacher, B.K. Tischer, S.M. Reddy, N. Osterrieder// J. Virol. -2001. -Dec.75(23)-P. 11 307−11 318.
- Sharma J.M. Virus-induced immunosuppression in chickens / J.M. Sharma, Π. Karaca, T. Pertile // Poult. Sci. -1994. -Julio73(7). -P. 1082−6.
- Shek W.R. Characterization of Marek’s disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells / S.W. Shek, B.W. Calnek, K.A. Schat, C.H. Chen // J. Natl. Cancer Inst. -1983. -Mar.70(3) -P.485−491.
- Shieh M.T. Cell surface receptors for herpes simplex virus are heparin sulfate proteoglycans / M.T. Shieh, D. WuDunn, R.I. Montgomery, J.D. Esko, P.G. Spear// J. Cell. Biol. -1992. -Mar. 116(5). -P. 1273−81.
- Silva R.F. Monoclonal antibody-mediated immunoprecipitation of proteins from cells infected with Marek’s disease virus or turkey herpesvirus / R.F. Silva, L.F. Lee // Virology. -1984. -Jul30.136(2). -P.307−20.
- Silva R.F. Expansion of a Unique Region in the Marek’s Disease Virus Genome Occurs Concomitantly with Attenuation but Is Not Sufficient To Cause Attenuation / R.F. Silva, S.M. Reddy, B. Lupiani // J Virol. 2004 Jan-78(2):733−40.
- Silva R.F. Genomic expansion of Marek’s disease virus DNA is associated with serial in vitro passage / R.F. Silva, R.L. Witter // J. Virol. -1985. -Jun.54(3). -P.690−966.
- Silva R.F. Oncogenic Marek’s disease viruses lacking the 132 base pair repeats can still be attenuated by serial in vitro cell culture passages / R.F. Silva, I. Gimeno //Virus Genes. -2007. -Jan.34(l). -P.87−90.
- Smyth J.A. Avian encephalomyelitis following oral vaccination / J.A. Smyth, F. McNeilly, G.A. Reilly, E.R. McKillop / Avian Pathol. -1994. -Sep.23(3). -P.435−445.
- Sokolowski M. Identification of herpes simplex virus RNAs that interact specifically with regulatory protein ICP27 in vivo / M. Sokolowski, J.E. Scott, R.P. Heaney, A.H. Patel, J.B. Clements // J. Biol. Chem. -2003. -Aug.29.278(35) -P.33 540−33 549.
- Solomon J J. Studies on the etiology of Marek’s disease. I. Propagation of the agent in cell culture / J.J. Solomon, R.L. Witter, K. Nazerian, B.R. Burmester // Proc. Soc. Exp. Biol. Med. -1968. -Jan.l27(l). -P. 173−177.
- Spatz S.J. Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek’s disease virus / S.J. Spatz, L. Petherbridge, Y. Zhao, V. Nair // J. Gen. Virol. -2007a. -Apr.88(Pt4). -P. 1080−1096.
- Spear P.G. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus / P.G. Spear, M.T. Shieh, B.C. Herold, D. WuDunn, T.I. Koshy // Adv. Exp. Med. Biol. -1992.-№ 313 -P.341−53.
- Tan X. Transcriptional analysis of Marek’s disease virus glycoprotein D, I, and E genes: gD expression is undetectable in cell culture / X. Tan, P. Brunovskis, L.F. Velicer // J. Virol. -2001. -Mar.75(5) -P.2067−2075.
- Tan J. Molecular evaluation of responses to vaccination and challenge by Marek’s disease viruses / J. Tan, J. Cooke, N. Clarke, G.A. Tannock // Avian Pathol. -2007. -Oct.36(5) P.351−359.
- Telford E.A. The DNA sequence of equine herpesvirus-1 / E.A. Telford, M.S. Watson, K. McBride, A.J. Davison // Virology. -1992. -Jul. 189(1) -P.304−16.
- Tengelsen L. A. Herpes simplex virus type 1 DNA cleavage and encap-sidation require the product of the UL28 gene: isolation and characterization of two
- UL28 deletion mutants / L.A. Tengelsen, N.E. Pederson, P.R. Shaver, M.W. Wathen, F.L. ΠΠΎΡΠ° // J Virol. -1993. -Jun.67(6) -P.3470−80.
- Tulman E. R. The genome of a very virulent Marek’s disease virus / E. R. Tulman, C. L. Afonso, Z. Lu, L. Zsak, D. L. Rock, G. F. Kutish // J. Virol. 2000. -№ 74. -P.7980- 7988.
- VanGuilder H.D. Twenty-five years of quantitative PCR for gene expression analysis. / H.D. VanGuilder, K.E. Vrana, W.M. Freeman // Biotechniques. -2008. -Apr.44(5). -P.619−626.
- Regenmortel M.H.V. Vims Taxonomy: The Seventh Report of the International Committee on Taxonomy of Viruses / M.H.V. van Regenmortel, C.M. Fau-quet, D.H.L. Bishop et all. Acad. Press, 2000. -P.1024.
- Watson R.J. Herpes Simplex Virus Type-1 Glycoprotein D Gene: Nucleotide Sequence And Expression In Escherichia Coli / R.J. Watson, J.H. Weis, J.S. Salstrom, L.W. Enquist // Science. -1982. -Oct.22218(4570). -P.381−384.
- Wilson M.R. Molecular analysis of the glycoprotein Π‘ negative phe-notype of attenuated Marek’s disease virus / M.R. Wilson, R. A. Southwick, J.T. Pulaski, V.L. Tieber, Y. Hong, P. M. Coussens // Virology. -1994. -№ 199. -P.393−402.
- Witter, R.L. Characteristics of Marek’s disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency / R.L. Witter //. Avian Dis. -1983. -№ 27(1). -P.l 13−132.
- Witter R.L. New serotype 2 and attenuated serotype 1 Marek’s disease vaccine viruses: selected biological and molecular characteristics / R.L. Witter, R.F. Silva, L.F. Lee // Avian Dis. -1987. -Oct.-Dec.31(4). -P.829−40.
- Witter R.L. Increased virulence of Marek’s disease virus field isolates / R.L. Witter // Avian. Dis. -1997a -Jan-Mar.41(l) -P.149−63.
- Witter R.L. Avian tumor viruses: persistent and evolving pathogens / R.L. Witter // Acta Vet. Hung. -1997b. -№ 45(3). -P.251−266.
- Witter R.L. Gimeno IM. Susceptibility of adult chickens, with and without prior vaccination, to challenge with Marek’s disease virus / R.L. Witter // Avian Dis. -2006. -Sep.50(3). -P.354−365.
- Wu P. Glycoproteins H and L of Marek’s disease virus form a hetero-oligomer essential for translocation and cell surface expression / P. Wu. W.M. Reed, L.F. Lee // Arch. Virol. -2001. -№ 146(5) -P.983−992.
- WuDunn D. Spear, P. G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate / D. WuDunn P.G. Spear // J. Virol. -1989. -Jan.63(l) -P.52−58.
- Xie Q. Marek’s disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells / Q. Xie, A.S. Anderson, R.W. Morgan // J. Virol. -1996.-Feb.70(2).-P.l 125−31.
- Xing Z. Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek’s disease virus / Z. Xing, K.A. Schat // J. Virol. -2000. -Apr.74(8). -P.3605−3612.
- Yanagida N. Nucleotide and predicted amino acid sequences of Marek’s disease virus homologues of herpes simplex virus major tegument proteins /N. Yanagida, S. Yoshida, K. Nazerian, L.F. Lee // J. Gen. Virol. -1993. -Sep.74(Pt9)-P. 1837−1845.
- Yoshida S. The glycoprotein Π genes of Marek’s disease virus serotypes 2 and 3: identification and expression by recombinant fowlpox viruses / S. Yoshida, L.F. Lee, N. Yanagida, K. Nazerian // Virology. -1994. -May 1.200(2) -P.484−93.
- Zelnik V. The complete sequence and gene organization of the short unique region of herpesvirus of turkeys / V. Zelnik, R. Darteil, J.C. Audonnet, G.D. Smith, M. Riviere, J. Pastorek, L.J. Ross // J. Gen. Virol. -1993. -Oct.74(PtlO).-P.2151−62.